Neonatal Hypoglycemia Related to Glycine Levels in Uncontrolled Gestational Diabetes Mellitus during Mid-Late Pregnancy: Multicenter, Prospective Case-Cohort Observational Study
Table 5
Correlations between neonate blood tests and maternal-fetal characteristics.
Glycine
Isovalerylcarnitine
Octenylcarnitine
Palmitoylcarnitine
Octadecylcarnitine
Octadecenoylcarnitine
GDM
0.084
<0.001
0.142
<0.001
0.158
<0.001
-0.071
<0.001
0.074
<0.001
0.036
0.002
Maternal age
-0.036
0.002
0.003
0.822
0.005
0.652
0.002
0.867
0.017
0.139
0.005
0.698
Gestational weeks
-0.027
0.023
-0.035
0.003
-0.051
<0.001
0.017
0.136
-0.010
0.374
-0.014
0.240
Antepartum BMI
0.009
0.465
-0.006
0.593
-0.022
0.060
0.002
0.895
-0.026
0.028
-0.015
0.191
Maternal HbA1c (average)
0.064
<0.001
0.085
<0.001
0.112
<0.001
-0.048
<0.001
0.047
<0.001
0.029
0.012
TG
-0.025
0.031
0.072
<0.001
0.063
<0.001
-0.044
<0.001
0.025
0.034
-0.001
0.901
Neonatal hypoglycemia
0.132
<0.001
0.035
0.002
0.040
0.001
-0.022
0.058
0.014
0.246
0.014
0.226
Premature
0.045
<0.001
0.007
0.551
0.260
0.026
-0.005
0.686
0.014
0.238
0.016
0.183
GDM: gestational diabetes mellitus; BMI: body mass index; HbA1c: glycosylated haemoglobin; TG: triglyceride.
